Brokers Set Expectations for Select Medical Q1 Earnings

Select Medical Holdings Co. (NYSE:SEM) – Stock analysts at Zacks Research issued their Q1 2025 earnings per share estimates for shares of Select Medical in a research report issued to clients and investors on Thursday, March 6th. Zacks Research analyst Z. Masood forecasts that the health services provider will post earnings of $0.43 per share for the quarter. The consensus estimate for Select Medical’s current full-year earnings is $1.17 per share. Zacks Research also issued estimates for Select Medical’s Q2 2025 earnings at $0.25 EPS, Q3 2025 earnings at $0.20 EPS, Q4 2025 earnings at $0.27 EPS, FY2025 earnings at $1.15 EPS, Q1 2026 earnings at $0.31 EPS, Q2 2026 earnings at $0.50 EPS, Q3 2026 earnings at $0.32 EPS, Q4 2026 earnings at $0.31 EPS and FY2026 earnings at $1.44 EPS.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.11). Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The business had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.50 billion.

Several other research analysts have also weighed in on SEM. Benchmark raised Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a research report on Monday, February 24th. UBS Group dropped their price target on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, February 21st. Finally, Royal Bank of Canada dropped their target price on Select Medical from $47.00 to $23.00 and set an “outperform” rating on the stock in a research report on Monday, February 24th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $27.25.

Select Medical Stock Down 2.4 %

NYSE:SEM opened at $16.99 on Monday. The firm has a market capitalization of $2.19 billion, a price-to-earnings ratio of 10.29, a PEG ratio of 0.64 and a beta of 1.56. Select Medical has a 1-year low of $16.20 and a 1-year high of $40.98. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The business’s fifty day moving average price is $18.88 and its 200 day moving average price is $26.62.

Select Medical Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 13th. Shareholders of record on Monday, March 3rd will be given a $0.0625 dividend. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.47%. Select Medical’s dividend payout ratio is currently 15.15%.

Institutional Trading of Select Medical

A number of hedge funds have recently modified their holdings of SEM. Kingsview Wealth Management LLC acquired a new position in shares of Select Medical in the 3rd quarter worth approximately $1,927,000. JPMorgan Chase & Co. raised its holdings in shares of Select Medical by 9.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 416,299 shares of the health services provider’s stock worth $14,516,000 after buying an additional 36,905 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in shares of Select Medical in the 3rd quarter worth approximately $1,592,000. Argent Capital Management LLC raised its holdings in shares of Select Medical by 79.8% in the 4th quarter. Argent Capital Management LLC now owns 55,144 shares of the health services provider’s stock worth $1,039,000 after buying an additional 24,471 shares in the last quarter. Finally, Geode Capital Management LLC raised its holdings in shares of Select Medical by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock worth $85,180,000 after buying an additional 46,880 shares in the last quarter. Institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.